Is CAVA's Store Expansion Strategy Built for Long-Term Efficiency? — Positive

CAVA   Zacks Investment Research — June 05, 2025

CAVA's disciplined store growth, rising same-store sales and tech-driven ops signal a model built for long-term gains.

image for news Is CAVA's Store Expansion Strategy Built for Long-Term Efficiency?

CNBC's Angelica Peebles sits down with Lilly's Head of Oncology, Jake Van Naarden, to discuss what's next in Lilly's oncology pipeline and what Lilly is changing about its clinical trials to make them easier for patients to participate in.

image for news Lilly's Jake Van Naarden: Lilly's success with GLP-1's allows us to reinvest in oncology

Duolingo: Playing Chess While Others Play Checkers — Positive

DUOL   Seeking Alpha — June 05, 2025

Duolingo delivered another outstanding quarter, with strong growth in revenue, users, and paid subscribers, showcasing its platform's power and engagement. AI is a core driver for Duolingo, enabling rapid course expansion, new features, and maintaining a clear edge over competitors in language learning. Despite a high valuation, Duolingo's premium business quality and consistent execution justify its price, making it a worthy long-term investment.

image for news Duolingo: Playing Chess While Others Play Checkers

Stock Market Live June 5: Trump and Xi Talk, S&P 500 (VOO) Rises — Neutral

VOO   24/7 Wall Street — June 05, 2025

China's President Xi and America's President Trump held a phone call to discuss trade matters this morning.

image for news Stock Market Live June 5: Trump and Xi Talk, S&P 500 (VOO) Rises

Arista Stock Surges 12.5% in 3 Months: Worth a Solid Buy? — Positive

ANET   Zacks Investment Research — June 05, 2025

ANET gains 12.5% in three months as strong demand, AI focus and software strength fuel investor optimism.

image for news Arista Stock Surges 12.5% in 3 Months: Worth a Solid Buy?

CVS Health Advances Digital Strategy: Is It the Next Revenue Pillar? — Neutral

CVS   Zacks Investment Research — June 05, 2025

CVS unveils a $20B digital strategy to tackle healthcare gaps and reshape consumer health experiences.

image for news CVS Health Advances Digital Strategy: Is It the Next Revenue Pillar?

Will the Launch of watsonx AI Labs Be a Game Changer for IBM? — Positive

IBM   Zacks Investment Research — June 05, 2025

IBM opens watsonx AI Labs in NYC to co-create enterprise AI with startups and scale-ups, boosting its AI innovation push.

image for news Will the Launch of watsonx AI Labs Be a Game Changer for IBM?

Costco Posts 6.8% Sales Growth in May, Slightly Slower Than April — Positive

COST   Investopedia — June 05, 2025

Costco Wholesale (COST) after the bell Wednesday said that its sales in May grew 6.8% year-over-year to $20.97 billion, slightly slower growth than the 7% that it saw in April compared to April 2024.

image for news Costco Posts 6.8% Sales Growth in May, Slightly Slower Than April

HUNTINGTON, W.Va. , June 5, 2025 /PRNewswire/ -- Energy Services of America (Nasdaq: ESOA), today announced its President, Doug Reynolds, and Chief Financial Officer, Charles Crimmel, will present at the East Coast IDEAS Investor Conference on Wednesday, June 11, 2025 in New York, NY.

image for news Energy Services of America to Present and Host 1x1 Investor Meetings at the 15th Annual East IDEAS Investor Conference on June 11

MongoDB soared on better-than-expected results and a guidance boost. "We are confident in our position to drive profitable growth as we benefit from this next wave of application development," said CEO and president Dev Ittycheria in a release.

image for news MongoDB jumps 15% after company boosts guidance, cites confidence in cloud-based database service

BLOOMINGTON, Minn. and SAN FRANCISCO , June 5, 2025 /PRNewswire/ -- CaringBridge, the nonprofit health communication platform, is partnering with DoorDash, the local commerce platform that connects people with their favorite businesses, to launch a special two-day fundraising match campaign on June 5th and 6th.

image for news CaringBridge and DoorDash Partner for Two-Day Fundraising Match to Support Family Caregivers

Best Growth Stocks to Buy for June 5th — Positive

GLDD  ODP  STRT   Zacks Investment Research — June 05, 2025

STRT, GLDD and ODP made it to the Zacks Rank #1 (Strong Buy) growth stocks list on June 5, 2025.

image for news Best Growth Stocks to Buy for June 5th

NEW YORK, June 05, 2025 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed against UroGen Pharma Ltd. (NASDAQ: URGN) (“UroGen” or the “Company”) The lawsuit is on behalf of individuals or entities that purchased or acquired UroGen Pharma Ltd. securities between July 27, 2023 and May 15, 2025 (the “Class Period”).

image for news Shareholders who lost money on UroGen Pharma Ltd. (NASDAQ: URGN) Should Contact Wolf Haldenstein

MUNICH & CHICAGO--(BUSINESS WIRE)-- #AI--Pricefx, the global leader in AI-powered pricing software, today announced the launch of its Negotiation Guidance solution on Salesforce AppExchange, a leading enterprise marketplace for partner apps and experts. With this new solution Pricefx will help manufacturing and distribution customers unlock greater value from various areas of revenue management, available through Salesforce AppExchange. The launch aims to streamline processes across sales agreements,.

image for news Pricefx Launches Negotiation Guidance Solution on Salesforce AppExchange to Transform Revenue Management

NEW YORK, NY / ACCESS Newswire / June 5, 2025 / If you suffered a loss on your BigBear.ai Holdings, Inc. (NYSE:BBAI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/bigbear-ai-holdings-inc-lawsuit-submission-form?prid=151770&wire=1&utm_campaign=3 or contact Joseph E. Levi, Esq.

image for news Securities Lawsuit Alert: BigBear.ai Holdings, Inc. (BBAI) - Contact Levi & Korsinsky Before June 10, 2025

NEW YORK, NY / ACCESS Newswire / June 5, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Rocket Pharmaceuticals, Inc. ("Rocket Pharmaceuticals, Inc.") (NASDAQ:RCKT) concerning possible violations of federal securities laws. Rocket issued a press release on May 27, 2025, "announc[ing] an update related to RP-A501, its investigational gene therapy for Danon disease.

image for news Investigation Opened on Behalf of Rocket Pharmaceuticals, Inc. (RCKT) Shareholders - Contact Levi & Korsinsky

NEW YORK, NY / ACCESS Newswire / June 5, 2025 / If you suffered a loss on your Treace Medical Concepts, Inc. (NASDAQ:TMCI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/treace-medical-concepts-inc-lawsuit-submission-form-2?prid=151775&wire=1&utm_campaign=2 or contact Joseph E. Levi, Esq.

image for news Securities Lawsuit Alert: Treace Medical Concepts, Inc. (TMCI) Investors - Contact Levi & Korsinsky Before June 10, 2025

NEW YORK, NY / ACCESS Newswire / June 5, 2025 / If you suffered a loss on your Rocket Companies, Inc. (NYSE:RKT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://www.zlk.com/pslra-1/rocket-companies-inc-loss-submission-form?prid=151768&wire=1&utm_campaign=17 or contact Joseph E. Levi, Esq.

image for news Class Action Alert: Levi & Korsinsky Reminds Rocket Companies (RKT) Investors of July 8, 2025 Deadline

NEW YORK, NY / ACCESS Newswire / June 5, 2025 / If you suffered a loss on your DoubleVerify Holdings, Inc. (NYSE:DV) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/doubleverify-holdings-inc-lawsuit-submission-form-2?prid=151772&wire=1&utm_campaign=21 or contact Joseph E. Levi, Esq.

image for news Shareholders of DoubleVerify Holdings, Inc. (DV): Protect Your Rights Before July 21, 2025 - Contact Levi & Korsinsky

NEW YORK, NY / ACCESS Newswire / June 5, 2025 / If you suffered a loss on your Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/iovance-biotherapeutics-inc-lawsuit-submission-form?prid=151773&wire=1&utm_campaign=11 or contact Joseph E. Levi, Esq.

image for news Investors in Iovance Biotherapeutics, Inc. (IOVA): Protect Your Rights - Contact Levi & Korsinsky Before July 14, 2025